March 6, 2016

Radius Health Submits New Drug Application to the U.S. Food and Drug Administration for Abaloparatide-SC for the Treatment of Postmenopausal Women with Osteoporosis

WALTHAM — Radius Health Inc., a biotech company that has operated largely under the radar for most of the past decade, is preparing later this month to submit its first drug for approval by US regulators.